Measuring liver blood flow during embolization
Part of Cancer clinical trials.
This study measures blood flow in the liver during a procedure called transarterial embolization, which blocks blood vessels to treat tumors. It may help doctors understand how to better plan treatments for liver conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to give your written permission to join the study.
- You must follow the study's schedule and procedures.
- You cannot be pregnant or breastfeeding.
- You cannot have advanced kidney disease (stage 4 or 5) unless you are on dialysis and not expected to recover.
- You cannot have a severe allergy to iodine dye that cannot be treated in advance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan to measure blood flow in the liver and detect liver damage. Researchers are testing whether this new imaging method can help diagnose liver disease early and track how well treatments are working.
This study measures how blood flow responds after a non-surgical energy test. It is likely looking for normal, healthy blood-flow reactions and how different people respond.
This study is testing a way to closely monitor blood flow and pressure during liver transplant surgery to help improve safety and outcomes. It may help patients undergoing a liver transplant.
This trial uses a special ultrasound with a contrast agent to see how well a liver cancer treatment called TACE is working. It may help doctors better understand if the treatment is shrinking the tumor.
This trial tests a device that checks how well blood flows in tiny vessels during your liver transplant surgery. It may help doctors better understand your body's response during the operation.
This trial tests a procedure to block abnormal blood vessels in the liver that bypass normal filtering, which causes confusion and brain problems in people with advanced liver disease. The goal is to reduce these episodes by redirecting blood flow through the liver where it can be properly cleaned.
Hear when a new Transarterial Chemoembolization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.